SODIUM CHLORIDE INJECTION USP 9 MG — DIN 00037796
SODIUM CHLORIDE : 9 MG · PFIZER CANADA ULC · SOLUTION · wholesale supply in Canada
Health Canada status: MARKETED
What is SODIUM CHLORIDE INJECTION USP?
SODIUM CHLORIDE INJECTION USP 9 MG contains SODIUM CHLORIDE : 9 MG. It is listed in the Health Canada Drug Product Database under DIN 00037796, held by PFIZER CANADA ULC, supplied as SOLUTION for INTRAMUSCULAR ; INTRAVENOUS ; INTRAPERITONEAL ; SUBCUTANEOUS administration. Health Canada currently lists it as marketed, status dated 30-Aug-2017. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Is there a generic Sodium Chloride in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
24 holders have a Canadian DIN containing Sodium Chloride, across 37 DINs, of which 11 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| BAXTER CORPORATION | 6 | 4 | 0.9% SODIUM CHLORIDE INJECTION, USP, 20% SODIUM CHLORIDE INJECTION, BP, 23.4% SODIUM CHLORIDE INJECTION USP, SODIUM CHLORIDE 0.45% INJ, SODIUM CHLORIDE 3% INJ, +1 more | Sourceable in Canada |
| B. BRAUN MEDICAL INC | 4 | 3 | 0.45% SODIUM CHLORIDE INJECTION USP, 0.9% SODIUM CHLORIDE INJECTION USP, 3% SODIUM CHLORIDE INJECTION USP, 5% SODIUM CHLORIDE INJECTION USP | Sourceable in Canada |
| FRESENIUS KABI CANADA LTD | 2 | 2 | 0.9% SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE INJECTION, USP | Sourceable in Canada |
| ICU MEDICAL CANADA INC | 2 | 1 | SODIUM CHLORIDE INJECTION USP | Sourceable in Canada |
| PFIZER CANADA ULC | 2 | 1 | SODIUM CHLORIDE INJECTION USP | Sourceable in Canada |
| INTERNATIONAL MEDICATION SYSTEMS LTD. | 2 | 0 | SODIUM CHLORIDE ADDITIVE SOLN 23.4%, SODIUM CHLORIDE INJ 0.9% | No marketed DIN |
| OMEGA LABORATORIES LIMITED | 2 | 0 | SODIUM CHLORIDE INJ 23.4%, SODIUM CHLORIDE INJECTION 0.9% USP | No marketed DIN |
| JUNO PHARMACEUTICALS CORP. | 1 | 0 | 0.9% SODIUM CHLORIDE INJECTION, USP | No marketed DIN |
| LABORATORIOS GRIFOLS S.A. | 1 | 0 | 0.9% SODIUM CHLORIDE INJECTION, USP | No marketed DIN |
| LYPHOMED, DIVISION OF FUJISAWA CANADA INC. | 1 | 0 | SODIUM CHLORIDE INJ 23.4% | No marketed DIN |
| MARCAN PHARMACEUTICALS INC | 1 | 0 | SODIUM CHLORIDE INJECTION USP | No marketed DIN |
| PREFFERED MEDICAL PRODUCTS, A DIVISION OF BALLARD MEDICAL PRODUCTS | 1 | 0 | SODIUM CHLORIDE INJ 0.9% USP | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 9 MG |
|---|---|
| Dosage form | SOLUTION |
| Route | INTRAMUSCULAR ; INTRAVENOUS ; INTRAPERITONEAL ; SUBCUTANEOUS |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Sodium Chloride |
|---|---|
| ATC code | B05XA03 |
| AHFS class | 40:12.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 00037796 |
|---|---|
| DIN (unpadded, as printed on some documents) | 37796 |
| Brand name | SODIUM CHLORIDE INJECTION USP |
| Generic / active ingredient | SODIUM CHLORIDE : 9 MG |
| Market authorization holder | PFIZER CANADA ULC |
| Health Canada schedule | Ethical |
| ATC code | B05XA03 |
| ATC anatomical main group | B — Blood and blood-forming organs |
| ATC therapeutic subgroup | B05XA |
| Current status | MARKETED |
| Status date | 30-Aug-2017 |
| Original market date | 1967-12-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
Is Sodium Chloride in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Active — reported by SANDOZ CANADA INCORPORATED, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
11 of 37 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| 0.45% SODIUM CHLORIDE INJECTION USP | 4.5 MG | SOLUTION | B. BRAUN MEDICAL INC | MARKETED | 01927949 |
| 0.9% SODIUM CHLORIDE INJECTION | 500ML | Solution | FRESENIUS KABI CANADA LTD | MARKETED | 02395150 |
| 0.9% SODIUM CHLORIDE INJECTION USP | 0.9 % | SOLUTION | B. BRAUN MEDICAL INC | MARKETED | 01924303 |
| 0.9% SODIUM CHLORIDE INJECTION, USP | 900 MG / 100 ML | SOLUTION | BAXTER CORPORATION | MARKETED | 00060208 |
| 20% SODIUM CHLORIDE INJECTION, BP | 20 % | SOLUTION | BAXTER CORPORATION | MARKETED | 02514184 |
| 5% SODIUM CHLORIDE INJECTION USP | 5 G / 100 ML | SOLUTION | B. BRAUN MEDICAL INC | MARKETED | 01928007 |
| SODIUM CHLORIDE 0.45% INJ | 450 MG / 100 ML | LIQUID | BAXTER CORPORATION | MARKETED | 00060186 |
| SODIUM CHLORIDE 3% INJ | 3 G / 100 ML | SOLUTION | BAXTER CORPORATION | MARKETED | 00060232 |
| SODIUM CHLORIDE INJECTION USP | 9 MG | SOLUTION | ICU MEDICAL CANADA INC | MARKETED | 00037842 |
| SODIUM CHLORIDE INJECTION, USP | 234 MG | SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED | 02139510 |
2 · Same class — other molecules in ATC B05XA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Sodium Chloride | 0.45% SODIUM CHLORIDE INJECTION USP · 0.9% SODIUM CHLORIDE INJECTION · 0.9% SODIUM CHLORIDE INJECTION USP · 0.9% SODIUM CHLORIDE INJECTION, USP · +23 more | 37 | 11 | Yes |
| Potassium Chloride | POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE · POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP · POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE, USP (2 MEQ/ML) · POTASSIUM CHLORIDE INJ 149MG/ML USP · +7 more | 17 | 7 | Yes |
| Sodium Bicarbonate | SODIUM BICARBONATE 5% INJ 50MG/ML USP · SODIUM BICARBONATE 5% INJ 5GM/100ML USP · SODIUM BICARBONATE INJ 4.2% · SODIUM BICARBONATE INJ 7.5% · +6 more | 18 | 5 | Yes |
| Electrolytes In Comb With Other Drugs | ADDNUTRIV · MICRO +4 REGULAR STRENGTH · MICRO PLUS 4 CONCENTRATE · MICRO PLUS 5 CONCENTRATE · +10 more | 14 | 5 | Yes |
| Calcium Gluconate | 2% CALCIUM GLUCONATE IN SODIUM CHLORIDE INJECTION · CALCIUM GLUCONATE IN SODIUM CHLORIDE INJECTION · CALCIUM GLUCONATE INJECTION USP 10% · CALCIUM GLUCONATE INJECTION, USP 10% | 5 | 5 | Yes |
| Magnesium Sulphate | MAGNESIUM SULFATE IN WATER FOR INJECTION · MAGNESIUM SULFATE INJ 50% · MAGNESIUM SULFATE INJECTION 50% USP · MAGNESIUM SULFATE INJECTION BP · +3 more | 9 | 4 | Yes |
| Zinc Sulfate | MICRO ZN · ZINC SULFATE INJECTION, USP | 4 | 4 | Yes |
| Potassium Phos Incl Comb W/0th Pot. Salts | POTASSIUM PHOSPHATE INJ 3MMP/ML · POTASSIUM PHOSPHATE MONOBASIC INJECTION · POTASSIUM PHOSPHATES · POTASSIUM PHOSPHATES INJ · +1 more | 5 | 3 | Yes |
| Calcium Chloride | CALCIJECT INJ 100MG/ML · CALCIUM CHLORIDE INJECTION BP · CALCIUM CHLORIDE INJECTION USP · CALCIUM-35 0.25 - 10 · +1 more | 5 | 2 | Yes |
| Sodium Acetate | 16.4% SODIUM ACETATE INJECTION, USP · SODIUM ACETATE INJ 328MG/ML USP · SODIUM ACETATE INJECTION USP · SODIUM ACETATE INJECTION, USP | 5 | 2 | Yes |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC B05X
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| B05XC | Vitamins | 9 | 2 |
| B05XX | Trometamol | 1 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.